Search

EHA-EBMT 3rd European CAR T-cell Meeting (Virtual)

Mar 05 2021 Posted in Meeting reports Tagged Immunotherapy, CAR T

Dates: February 4-6, 2021

Chairs: H Einsele (EHA) & C Chabannon (EBMT)

For the 3rd time now the European Hematology Association (EHA) and the European Society for Blood and Marrow Transplantation (EBMT) jointly organized the European CAR T-cell Meeting; this year in…

Treatment, medicine and hematology research: What patients want and doctors need (to know)

Mar 25 2014 Posted in Press releases

Jan Geissler, a Patient Advocate remarked about the Congress: “Over and above scientific updates, much can be achieved in partnership between hematologists and patients.

Is CRTH for me?

Eligibility
Applicant must be a trainee or junior faculty and hold an MD or MD/PhD
Applicant must be actively employed in a hematology or hematology-related research environment
The applicant must be an EHA member or EHA Guest at the time of application submission…

The root of evil: pre-leukemic clones that survive chemotherapy are linked to a higher risk of leukemia recurrence

Jun 10 2016 Posted in Press releases

Acute myeloid leukemia (AML) is an aggressive form of blood cancer. Treatment with intensive chemotherapy often leads to a period of freedom from overt disease called a remission. However, recurrence of the disease is common.

Congress Sponsor Program

Join us at the EHA Annual Congress, where you have the unique opportunity to connect and grow with a community of hematology experts.